KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $719,127,000 | +34.7% | 6,936,691 | +1.9% | 0.22% | +33.9% |
Q1 2017 | $534,069,000 | +94.9% | 6,804,291 | +11.4% | 0.17% | +88.8% |
Q4 2016 | $273,962,000 | -19.3% | 6,109,771 | +0.6% | 0.09% | -20.5% |
Q3 2016 | $339,384,000 | +12.9% | 6,075,623 | +1.0% | 0.11% | +8.7% |
Q2 2016 | $300,723,000 | +9.5% | 6,014,453 | +0.5% | 0.10% | +8.4% |
Q1 2016 | $274,668,000 | -25.0% | 5,982,753 | +0.7% | 0.10% | -24.0% |
Q4 2015 | $365,995,000 | +22.7% | 5,939,553 | +10.9% | 0.12% | +16.8% |
Q3 2015 | $298,303,000 | -10.8% | 5,357,460 | -2.3% | 0.11% | -2.7% |
Q2 2015 | $334,401,000 | +13.1% | 5,484,685 | +7.0% | 0.11% | +8.9% |
Q1 2015 | $295,603,000 | +32.9% | 5,124,885 | +32.9% | 0.10% | +32.9% |
Q4 2014 | $222,442,000 | +239.6% | 3,857,147 | +61.4% | 0.08% | +230.4% |
Q3 2014 | $65,505,000 | – | 2,389,185 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |